Standard Chemical & Pharmaceutical monthly revenue
Standard Chemical & Pharmaceutical Co
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$0.6B | +5.9% | +9.1% | NT$3.5B |
| May 2026 | Jun 17, 2026 | NT$0.6B | -14.2% | -5.0% | NT$2.9B |
| Apr 2026 | May 17, 2026 | NT$0.7B | +18.8% | +3.8% | NT$2.3B |
| Mar 2026 | Apr 17, 2026 | NT$0.6B | +22.3% | +2.8% | NT$1.7B |
| Feb 2026 | Mar 17, 2026 | NT$0.5B | -24.2% | -16.4% | NT$1.1B |
| Jan 2026 | — | NT$0.6B | — | +16.6% | NT$0.6B |
| Dec 2025 | — | NT$0.6B | — | +4.8% | NT$7B |
| Nov 2025 | — | NT$0.6B | — | -2.9% | NT$6.5B |
| Oct 2025 | — | NT$0.6B | — | +19.4% | NT$5.9B |
| Sep 2025 | — | NT$0.6B | — | +9.0% | NT$5.2B |
| Aug 2025 | — | NT$0.6B | — | -2.3% | NT$4.6B |
| Jul 2025 | — | NT$0.6B | — | -2.1% | NT$4B |
| Jun 2025 | — | NT$0.6B | — | +0.2% | NT$3.5B |
| May 2025 | — | NT$0.6B | — | +2.6% | NT$2.9B |
| Apr 2025 | — | NT$0.7B | — | +8.6% | NT$2.3B |
| Mar 2025 | — | NT$0.6B | — | +5.4% | NT$1.6B |
| Feb 2025 | — | NT$0.6B | — | +25.4% | NT$1.1B |
| Jan 2025 | — | NT$0.5B | — | -17.9% | NT$0.5B |
| Dec 2024 | — | NT$0.5B | — | +7.3% | NT$6.8B |
| Nov 2024 | — | NT$0.6B | — | +2.3% | NT$6.2B |
| Oct 2024 | — | NT$0.5B | — | +5.4% | NT$5.7B |
| Sep 2024 | — | NT$0.6B | — | +16.5% | NT$5.1B |
| Aug 2024 | — | NT$0.6B | — | +1.1% | NT$4.5B |
| Jul 2024 | — | NT$0.6B | — | +1.7% | NT$3.9B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-07-29. Source: Taiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.